567 related articles for article (PubMed ID: 34929169)
1. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
[TBL] [Abstract][Full Text] [Related]
2. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.
Mycroft-West CJ; Su D; Pagani I; Rudd TR; Elli S; Gandhi NS; Guimond SE; Miller GJ; Meneghetti MCZ; Nader HB; Li Y; Nunes QM; Procter P; Mancini N; Clementi M; Bisio A; Forsyth NR; Ferro V; Turnbull JE; Guerrini M; Fernig DG; Vicenzi E; Yates EA; Lima MA; Skidmore MA
Thromb Haemost; 2020 Dec; 120(12):1700-1715. PubMed ID: 33368089
[TBL] [Abstract][Full Text] [Related]
3. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.
Clausen TM; Sandoval DR; Spliid CB; Pihl J; Perrett HR; Painter CD; Narayanan A; Majowicz SA; Kwong EM; McVicar RN; Thacker BE; Glass CA; Yang Z; Torres JL; Golden GJ; Bartels PL; Porell RN; Garretson AF; Laubach L; Feldman J; Yin X; Pu Y; Hauser BM; Caradonna TM; Kellman BP; Martino C; Gordts PLSM; Chanda SK; Schmidt AG; Godula K; Leibel SL; Jose J; Corbett KD; Ward AB; Carlin AF; Esko JD
Cell; 2020 Nov; 183(4):1043-1057.e15. PubMed ID: 32970989
[TBL] [Abstract][Full Text] [Related]
5. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
Kim SY; Jin W; Sood A; Montgomery DW; Grant OC; Fuster MM; Fu L; Dordick JS; Woods RJ; Zhang F; Linhardt RJ
Antiviral Res; 2020 Sep; 181():104873. PubMed ID: 32653452
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
7. Marine Sulfated Polysaccharides as Promising Antiviral Agents: A Comprehensive Report and Modeling Study Focusing on SARS CoV-2.
Salih AEM; Thissera B; Yaseen M; Hassane ASI; El-Seedi HR; Sayed AM; Rateb ME
Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436245
[TBL] [Abstract][Full Text] [Related]
8. Marine sulfated glycans inhibit the interaction of heparin with S-protein of SARS-CoV-2 Omicron XBB variant.
He P; Song Y; Jin W; Li Y; Xia K; Kim SB; Dwivedi R; Farrag M; Bates J; Pomin VH; Wang C; Linhardt RJ; Dordick JS; Zhang F
Glycoconj J; 2024 Apr; 41(2):163-174. PubMed ID: 38642280
[TBL] [Abstract][Full Text] [Related]
9. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.
Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN
Cells; 2021 Jun; 10(6):. PubMed ID: 34200372
[TBL] [Abstract][Full Text] [Related]
10. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
11.
Pandey AK; Verma S
Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
[TBL] [Abstract][Full Text] [Related]
12. Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.
Tandon R; Sharp JS; Zhang F; Pomin VH; Ashpole NM; Mitra D; McCandless MG; Jin W; Liu H; Sharma P; Linhardt RJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33173010
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
Lavie M; Dubuisson J; Belouzard S
J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
[TBL] [Abstract][Full Text] [Related]
14. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
15. Structurally defined heparin octasaccharide domain for binding to SARS-CoV-2 Omicron BA.4/BA.5/BA.5.2 spike protein RBD.
An Z; Bu C; Shi D; Chen Q; Zhang B; Wang Q; Jin L; Chi L
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129032. PubMed ID: 38159696
[TBL] [Abstract][Full Text] [Related]
16. Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein.
Shi Y; Zeida A; Edwards CE; Mallory ML; Sastre S; Machado MR; Pickles RJ; Fu L; Liu K; Yang J; Baric RS; Boucher RC; Radi R; Carroll KS
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35074895
[TBL] [Abstract][Full Text] [Related]
17. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment.
Li J; Xu D; Wang L; Zhang M; Zhang G; Li E; He S
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684671
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
Idrees D; Kumar V
Biochem Biophys Res Commun; 2021 May; 554():94-98. PubMed ID: 33789211
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
